Total Credits: .75 including .75 AMA PRA Category 1 Credit(s)™, .75 AOA Category 1-A Credit(s)
This program will expire and must be completed by 03/16/25.
*** Meets DEA Requirements ***
*** Please note this program will also be found as part of the 3.25-Credit program Pain & Pain Management. If you have already completed Pain & Pain Management, you will not want to choose this program. If you would like to learn more about Pain & Pain Management, choose “Media Types” above and select “Classroom.” ***
Dr. Iszard will discuss and review recent events in the opioid crisis in the U.S. from 2009-current. He will also discuss the epidemiology of the opioid crisis, prevention of Lethal Opioid Overdose in the Community, Community-Based intervention, and review the value of Community-Based Naloxone.
Learning Objectives:
Accreditation Statements:
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of .75 AOA Category 1-A Credits and will report CME and specialty credits commensurate with the extent of the physician's participation.
Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of .75 AMA PRA Category 1 Creditsä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and Kansas City University College of Osteopathic Medicine. MAOPS is accredited by the ACCME to provide continuing medical education for physicians.
Planning Disclosure:
None of the planners for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Grievance Policy for AOA Credit:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
| Update 2021 - Opioids (2.13 MB) | 26 Pages | Available after Purchase |
Dr. Iszard serves as an Associate Professor at Kansas City University. He has been in academic medicine for over twenty-five years. He started his career in Louisiana after postdoctoral fellowship at University of Kansas School of Medicine, Department of Pharmacology, Toxicology and Therapeutics in Kansas City, Kansas. He has published several articles and presented nationally.
Dr. Iszard discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
Dr. Iszard can be reached at miszard@kansascity.edu or 417-208-0660
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|